{"id":"W4283775908","doi":"10.1016/j.annonc.2022.06.011","title":"Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Olaparib; Medicine; Hazard ratio; Internal medicine; Placebo; Chemotherapy; Oncology; Ovarian cancer; Population; Cohort; Surgery; Cancer; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002173211,0.001531542,0.003849203,0.0002642001,0.0002794202,0.001179949,0.0008404952,0.001097033,0.004342902],"category_scores_gemma":[0.002788482,0.0004602519,0.004061181,0.0002911041,0.0007730158,0.001308822,0.0004841969,0.003983176,0.0005209019],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007456054,"about_ca_system_score_gemma":0.0007604589,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007622765,"about_ca_topic_score_gemma":0.001981172,"domain_scores_codex":[0.9989609,0.0006474102,0.00005258824,0.0001700979,0.00004298181,0.000126035],"domain_scores_gemma":[0.9986235,0.0006881176,0.0002442111,0.0001415545,0.00005035905,0.0002523178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.981137,0.0008965482,0.001056949,0.0002856542,0.002475645,0.00002880089,0.00003749441,0.0006933804,0.001187137,0.00007120388,0.0003701689,0.01176005],"study_design_scores_gemma":[0.7701977,0.1921643,0.02019194,0.000142026,0.009447207,0.0001193669,0.0001435473,0.002878539,0.001732871,0.001017993,0.001900839,0.00006366111],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911389,0.004724994,0.0003414841,0.0005496313,0.0003650975,0.0003424097,0.0007206109,0.00005653292,0.001760339],"genre_scores_gemma":[0.995084,0.001259616,0.0002936945,0.0003858753,0.0001922686,0.0002518291,0.0007385592,0.00001766929,0.001776445],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004342902,"threshold_uncertainty_score":0.01452851,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1289920043521299,"score_gpt":0.4438730939755801,"score_spread":0.3148810896234502,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}